Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Sep 25:11:585930.
doi: 10.3389/fphar.2020.585930. eCollection 2020.

IRAP Inhibitors: M1-Aminopeptidase Family Inspiration

Nicholas Barlow  1 , Philip E Thompson  1
Affiliations
Review

IRAP Inhibitors: M1-Aminopeptidase Family Inspiration

Nicholas Barlow et al. Front Pharmacol. .

Abstract

The insulin regulated aminopeptidase (IRAP) has been proposed as an important therapeutic target for indications including Alzheimer's disease and immune disorders. To date, a number of IRAP inhibitor designs have been investigated but the total number of molecules investigated remains quite small. As a member the M1 aminopeptidase family, IRAP shares numerous structural features with the other M1 aminopeptidases. The study of those enzymes and the development of inhibitors provide key learnings and new approaches and are potential sources of inspiration for future IRAP inhibitors.

Keywords: insulin regulated aminopeptidase; aminopeptidase; enzyme inhibitor design; peptidomimetic; small molecule inhibitor; transition state analog.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Chemical structures of IRAP inhibitors.
Figure 2
Figure 2
M1 aminopeptidase inhibitors from other families.
See this image and copyright information in PMC

References

    1. Albiston A. L., McDowall S. G., Matsacos D., Sim P., Clune E., Mustafa T., et al. (2001). Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase. J. Biol. Chem. 276, 48623–48626. 10.1074/jbc.C100512200 - DOI - PubMed
    1. Albiston A. L., Morton C. J., Ng H. L., Pham V., Yeatman H. R., Ye S., et al. (2008). Identification and characterization of a new cognitive enhancer based on inhibition of insulin-regulated aminopeptidase. FASEB J. 22, 4209–4217. 10.1096/fj.08-112227 - DOI - PubMed
    1. Amin S. A., Adhikari N., Jha T. (2018). Design of Aminopeptidase N Inhibitors as Anti-cancer Agents. J. Med. Chem. 61, 6468–6490. 10.1021/acs.jmedchem.7b00782 - DOI - PubMed
    1. Andersson H., Demaegdt H., Vauquelin G., Lindeberg G., Karlen A., Hallberg M., et al. (2010). Disulfide cyclized tripeptide analogues of angiotensin IV as potent and selective inhibitors of insulin-regulated aminopeptidase (IRAP). J. Med. Chem. 53, 8059–8071. 10.1021/jm100793t - DOI - PubMed
    1. Andersson H., Demaegdt H., Johnsson A., Vauquelin G., Lindeberg G., Hallberg M., et al. (2011). Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis. J. Med. Chem. 54, 3779–3792. 10.1021/jm200036n - DOI - PubMed